GlobalData on MSN
Takeda’s oral TYK2 blocker outperforms Sotyktu in PsA trial
Based on this data and data from two other Phase III trials, Takeda will file for the approval of zasocitinib in PsA.
A sheriff says John Hamilton was a respected and experienced employee at Cairnryan.
Takeda Pharmaceutical Company Limited TAK on Thursday shared topline results for the Phase 3 comparing zasocitinib (TAK-279) to Bristol-Myers Squibb Co.’s BMY Sotyktu (deucravacitinib) in adults with ...
Iren representatives answer questions about a proposed data center in Pittsburg County that will go near Kiowa. Questions were compiled by MN-C staff. What does a data center do? A data center is ...
The best films of 1981 made it easy to ignore the major misfires.
Path of Exile 2 patch 0.5.4 adds a new Expedition Atlas Passive skill tree designed to work with Runes of Aldur, plus more ...
GREEN RIVER, Emery County — The forces involved in a proposed nuclear energy development in the Brigham City area are now involved in a parallel nuclear initiative in Emery County that dates back ...
HUNTSVILLE, Ala. (WAFF) - Growth is refusing to stop in North Huntsville, especially near the Northern Bypass. On Wednesday night, the Huntsville Planning Commission approved the rezoning of an ...
The Dallas Cowboys, in the words of head coach Brian Schottenheimer, are never closed for business. With that being said, they're also comfortable with many parts of their current roster, including at ...
AbbVie maintains strong momentum in immunology, with Skyrizi and Rinvoq offsetting Humira declines and driving double-digit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results